EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,077,839 | +12.9% | 278,162 | -1.3% | 0.00% | 0.0% |
| Q2 2023 | $5,385,752 | -1.1% | 281,829 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $5,442,913 | -5.2% | 280,418 | -21.6% | 0.00% | 0.0% |
| Q4 2022 | $5,739,048 | +48.1% | 357,796 | +44.8% | 0.00% | +100.0% |
| Q3 2022 | $3,875,000 | -19.4% | 247,139 | +7.0% | 0.00% | -50.0% |
| Q2 2022 | $4,810,000 | +191.0% | 231,029 | +216.9% | 0.00% | – |
| Q1 2022 | $1,653,000 | -23.0% | 72,908 | -37.9% | 0.00% | -100.0% |
| Q4 2021 | $2,147,000 | +443.5% | 117,413 | +527.7% | 0.00% | – |
| Q3 2021 | $395,000 | -99.1% | 18,704 | -99.2% | 0.00% | -100.0% |
| Q2 2021 | $42,460,000 | -32.2% | 2,330,409 | -15.9% | 0.01% | -36.8% |
| Q1 2021 | $62,591,000 | -12.4% | 2,770,751 | -22.2% | 0.02% | -17.4% |
| Q4 2020 | $71,474,000 | -13.9% | 3,561,236 | +4.9% | 0.02% | -23.3% |
| Q3 2020 | $83,023,000 | +55.9% | 3,395,577 | +51.4% | 0.03% | +42.9% |
| Q2 2020 | $53,240,000 | +30150.0% | 2,242,626 | +21882.2% | 0.02% | – |
| Q1 2020 | $176,000 | -69.4% | 10,202 | -68.7% | 0.00% | – |
| Q4 2019 | $575,000 | -10.0% | 32,613 | -9.8% | 0.00% | – |
| Q3 2019 | $639,000 | +197.2% | 36,137 | +273.1% | 0.00% | – |
| Q1 2018 | $215,000 | – | 9,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |